These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36792311)

  • 1. Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis.
    Park EH; Kang EH; Lee YJ; Ha YJ
    RMD Open; 2023 Feb; 9(1):. PubMed ID: 36792311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis.
    Shin S; Park EH; Kang EH; Lee YJ; Song YW; Ha YJ
    Joint Bone Spine; 2021 May; 88(3):105124. PubMed ID: 33346105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.
    Wong LE; Huang WT; Pope JE; Haraoui B; Boire G; Thorne JC; Hitchon CA; Tin D; Keystone EC; Bykerk VP;
    Arthritis Care Res (Hoboken); 2015 May; 67(5):616-23. PubMed ID: 25303739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine.
    Al-Jabi SW; Seleit DI; Badran A; Koni A; Zyoud SH
    Health Qual Life Outcomes; 2021 Oct; 19(1):241. PubMed ID: 34645455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
    Bae SC; Cho SK; Won S; Lee HS; Lee SH; Kang YM; Lee SH; Lee YA; Choe JY; Chung WT; Suh CH; Shim SC; Lee J; Yoon BY; Kim DW; Lee SS; Yoo WH; Kim JS; Jung YO; Nah SS; Lee CK; Song GG; Choi SJ; Joung CI; Koh H; Kim YJ
    Int J Rheum Dis; 2018 May; 21(5):1001-1009. PubMed ID: 29878615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients.
    Lee HJ; Pok LSL; Ng CM; Yahya F; Sockalingam S; Tee YC; Raja J
    Int J Rheum Dis; 2020 Aug; 23(8):1088-1093. PubMed ID: 32597545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study.
    Scott IC; Mount J; Barry J; Kirkham B
    BMC Rheumatol; 2020; 4():63. PubMed ID: 33094270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
    Bergman M; Tundia N; Martin N; Suboticki JL; Patel J; Goldschmidt D; Song Y; Wright GC
    Arthritis Res Ther; 2022 Jun; 24(1):155. PubMed ID: 35751108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.
    Wallman JK; Eriksson JK; Nilsson JÅ; Olofsson T; Kristensen LE; Neovius M; Geborek P
    J Rheumatol; 2016 Jul; 43(7):1292-9. PubMed ID: 27252420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS).
    Blauvelt A; Leonardi CL; Gaylis N; Jauch-Lembach J; Balfour A; Lemke L; Hachaichi S; Brueckmann I; Festini T; Wiland P
    BioDrugs; 2021 Mar; 35(2):229-238. PubMed ID: 33651341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A; Fernández I; Badia X; Varela C; Roset M
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
    Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
    Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
    Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
    Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.
    Austad C; Kvien TK; Olsen IC; Uhlig T
    Scand J Rheumatol; 2017 Mar; 46(2):95-103. PubMed ID: 27319613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.
    Strand V; Gossec L; Proudfoot CWJ; Chen CI; Reaney M; Guillonneau S; Kimura T; van Adelsberg J; Lin Y; Mangan EK; van Hoogstraten H; Burmester GR
    Arthritis Res Ther; 2018 Jun; 20(1):129. PubMed ID: 29921318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.
    Hoshi D; Tanaka E; Igarashi A; Inoue E; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Tsutani K; Yamanaka H
    Mod Rheumatol; 2016; 26(1):40-5. PubMed ID: 26052801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database.
    Sakai R; Tanaka E; Inoue E; Sato M; Tanaka M; Ikari K; Yamanaka H; Harigai M
    Mod Rheumatol; 2023 Apr; 33(3):496-502. PubMed ID: 35652691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.